Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Clinical trial NCT05282420 · UNKNOWN

Trial details

NCT number: NCT05282420
Sponsor: South Valley University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema

Start date: 2021-02-01
Primary completion: 2022-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.